We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Magnetic Stimulation Improves Neuropathy Fecal Incontinence

By HospiMedica International staff writers
Posted on 07 Sep 2020
Translumbosacral neuromodulation therapy (TNT) of nerves that regulate muscles in the anus and rectum dramatically reduce episodes of fecal incontinence (FI), according to a new study. More...


Researchers at the Medical College of Georgia (MCG; Augusta USA) and the University of Manchester (United Kingdom) conducted a study involving 33 patients with FI (23 women, average 60 years of age) who were randomized to receive six sessions of weekly TNT treatments. The treatment consisted of 600 repetitive magnetic stimulations over each of two lumbar and two sacral sites with 1, 5, or 15 Hz frequency stimulations. Stool diaries, FI severity indices, anorectal neurophysiology, sensorimotor function, and quality of life were compared.

The results revealed that FI episodes decreased significantly in all the groups when compared with baseline; but the 1 Hz group showed a significantly higher responder rate when compared with the 5 Hz group or 15 Hz groups. No difference was found between the 5 and 15 Hz groups. Anal neuropathy, squeeze pressure, and rectal capacity improved significantly only in the 1 Hz group compared with baseline, but not in other groups. And quality of life domains improved significantly within the 1 and 5 Hz groups. The study was published on July 29, 2020, in The American Journal of Gastroenterology.

“We found there was significant improvement in fecal incontinence across the board, which told us something is happening with this treatment. There is an effect on nerve function which, in turn, is leading to improvement of symptoms,” said lead author Satish Rao MD, PhD, of MCG. “We have identified that nerve damage is an important mechanism in the pathogenesis of stool leakage. A noninvasive and targeted treatment to correct the nerve damage addresses this pervasive problem.”

Fecal incontinence, also known as accidental bowel leakage (ABL), is the inability to control bowel movements and is a common problem, especially among older adults. FI particularly affects women who have experienced pregnancy, childbirth, or nerve or muscle damage in the pelvic region. As there are multiple causes for bowel control problems, effective treatment is particularly difficult, and usually includes dietary modification, medical management, physical therapy, and often surgery or surgical implants. FI impacts women about twice as often as men.

Related Links:
Medical College of Georgia
University of Manchester



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Emergency Ventilator
Shangrila935
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.